Table 3.
Regimen | Number of Regimens | CR n (%) |
PR n (%) |
SD n (%) |
PD n (%) |
Unknown n (%) |
---|---|---|---|---|---|---|
Platinum-based | 37 | 4 (11) | 11 (30) | 10 (27) | 10 (27) | 2 (5) 1 |
Taxane-based | 9 | 0 (0) | 2 (22) | 3 (33) | 4 (45) | 0 (0) |
Platinum taxane combination | 6 | 2 (33) | 0 (0) | 2 (33) | 2 (33) | 0 (0) |
Other 2 | 6 | 0 (0) | 0 (0) | 1 (17) | 5 (83) | 0 (0) |
Total | 58 | 6 (10) | 13 (22) | 16 (28) | 21 (36) | 2 (4) |
1 One response not stated, one patient stopped due to toxicity; 2 including 5-fluorouracil, chlorambucil, doxorubicin and cyclophosphamide. CR: complete response, PR: partial response, SD: stable disease, PD: progressive disease.